BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 19467742)

  • 21. Selective recognition of G-qQuadruplex telomeric DNA by a bis(quinacridine) macrocycle.
    Teulade-Fichou MP; Carrasco C; Guittat L; Bailly C; Alberti P; Mergny JL; David A; Lehn JM; Wilson WD
    J Am Chem Soc; 2003 Apr; 125(16):4732-40. PubMed ID: 12696891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling and biological investigations of an unusual behavior of novel synthesized acridine-based polyamine ligands in the binding of double helix and G-quadruplex DNA.
    Bazzicalupi C; Chioccioli M; Sissi C; Porcù E; Bonaccini C; Pivetta C; Bencini A; Giorgi C; Valtancoli B; Melani F; Gratteri P
    ChemMedChem; 2010 Dec; 5(12):1995-2005. PubMed ID: 20957717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence-based melting assays for studying quadruplex ligands.
    De Cian A; Guittat L; Kaiser M; Saccà B; Amrane S; Bourdoncle A; Alberti P; Teulade-Fichou MP; Lacroix L; Mergny JL
    Methods; 2007 Jun; 42(2):183-95. PubMed ID: 17472900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay.
    Mergny JL; Lacroix L; Teulade-Fichou MP; Hounsou C; Guittat L; Hoarau M; Arimondo PB; Vigneron JP; Lehn JM; Riou JF; Garestier T; Hélène C
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3062-7. PubMed ID: 11248032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase.
    Zhou JL; Lu YJ; Ou TM; Zhou JM; Huang ZS; Zhu XF; Du CJ; Bu XZ; Ma L; Gu LQ; Li YM; Chan AS
    J Med Chem; 2005 Nov; 48(23):7315-21. PubMed ID: 16279791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA.
    Tan JH; Ou TM; Hou JQ; Lu YJ; Huang SL; Luo HB; Wu JY; Huang ZS; Wong KY; Gu LQ
    J Med Chem; 2009 May; 52(9):2825-35. PubMed ID: 19354252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural investigations of acridine derivatives by CoMFA and CoMSIA reveal novel insight into their structures toward DNA G-quadruplex mediated telomerase inhibition and offer a highly predictive 3D-model for substituted acridines.
    Zambre VP; Murumkar PR; Giridhar R; Yadav MR
    J Chem Inf Model; 2009 May; 49(5):1298-311. PubMed ID: 19413274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platinum(II) phenanthroimidazoles for targeting telomeric G-quadruplexes.
    Castor KJ; Mancini J; Fakhoury J; Weill N; Kieltyka R; Englebienne P; Avakyan N; Mittermaier A; Autexier C; Moitessier N; Sleiman HF
    ChemMedChem; 2012 Jan; 7(1):85-94. PubMed ID: 22052801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase.
    Guyen B; Schultes CM; Hazel P; Mann J; Neidle S
    Org Biomol Chem; 2004 Apr; 2(7):981-8. PubMed ID: 15034620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRACO19 analog dimers with improved inhibition of telomerase and hPot 1.
    Fu YT; Keppler BR; Soares J; Jarstfer MB
    Bioorg Med Chem; 2009 Mar; 17(5):2030-7. PubMed ID: 19201200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A platinum supramolecular square as an effective G-quadruplex binder and telomerase inhibitor.
    Kieltyka R; Englebienne P; Fakhoury J; Autexier C; Moitessier N; Sleiman HF
    J Am Chem Soc; 2008 Aug; 130(31):10040-1. PubMed ID: 18616250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disubstituted quinazoline derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA.
    Li Z; Tan JH; He JH; Long Y; Ou TM; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2012 Jan; 47(1):299-311. PubMed ID: 22104971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives.
    Zagotto G; Sissi C; Moro S; Dal Ben D; Parkinson GN; Fox KR; Neidle S; Palumbo M
    Bioorg Med Chem; 2008 Jan; 16(1):354-61. PubMed ID: 17936629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacophore-based discovery of triaryl-substituted imidazole as new telomeric G-quadruplex ligand.
    Chen SB; Tan JH; Ou TM; Huang SL; An LK; Luo HB; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1004-9. PubMed ID: 21211968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disubstituted 2-phenyl-benzopyranopyrimidine derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA.
    Wu WB; Chen SH; Hou JQ; Tan JH; Ou TM; Huang SL; Li D; Gu LQ; Huang ZS
    Org Biomol Chem; 2011 Apr; 9(8):2975-86. PubMed ID: 21373680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.
    Harrison RJ; Cuesta J; Chessari G; Read MA; Basra SK; Reszka AP; Morrell J; Gowan SM; Incles CM; Tanious FA; Wilson WD; Kelland LR; Neidle S
    J Med Chem; 2003 Oct; 46(21):4463-76. PubMed ID: 14521409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
    Gunaratnam M; Neidle S
    Methods Mol Biol; 2010; 613():303-13. PubMed ID: 19997892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.